Inventor · disambiguated record
Jerry Nzerem
Also filed as: NZEREM JERRY
14 granted patents·2 pending applications·60 citations·filing 2013–2023
90Inventor score
Top patents by PatentIndex Score
16 records- 0196US10493077B2Fused imidazo-piperidine JAK inhibitor compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Dec 3, 2019·14 cites·19 claims
- 0296US10308646B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Jun 4, 2019·11 cites·32 claims
- 0395US10251874B2Crystalline forms of a JAK inhibitor compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Apr 9, 2019·23 cites·23 claims
- 0488US12172994B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2023·Granted Dec 24, 2024·0 cites·19 claims
- 0587US10538513B2Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Jan 21, 2020·4 cites·16 claims
- 0685US10392368B2Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Aug 27, 2019·5 cites·46 claims
- 0783US10968205B2Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Apr 6, 2021·1 cites·26 claims
- 0882US11814377B2Pyrimidine compound as JAK kinase inhibitorTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Granted Nov 14, 2023·0 cites·19 claims
- 0982US11160810B2Fused imidazo-piperidine JAK inhibitor compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Nov 2, 2021·2 cites·27 claims
- 1070US2022119369A1Pyrazolo and triazolo bicyclic compounds as jak kinase inhibitorsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2021·Application pending·0 cites
- 1160US9868698B2(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acidTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2017·Granted Jan 16, 2018·0 cites·2 claims
- 1257US9433598B2(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acidTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Sep 6, 2016·0 cites·26 claims
- 1356US9670143B2(2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxmethyl-2-methylpentanoic acidTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Jun 6, 2017·0 cites·2 claims
- 1449US2022306626A1Crystalline form of a dihydrochloride salt of a jak inhibitor compoundTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2022·Application pending·0 cites
- 1545US8883135B2Crystalline form of a pyridyl-piperazinyl hepatitis C virus inhibitorTHALLADI VENKAT R·Filed 2013·Granted Nov 11, 2014·0 cites·27 claims
- 1640US9271965B2Crystalline forms of (R)-3-[N-(3'-chlorobiphenyl-4-ylmethyl)-N'-(3-hydroxyisoxazole-5-carbonyl)hydrazino]-2-hydroxyproprionic acid isopropyl esterTHALLADI VENKAT R·Filed 2013·Granted Mar 1, 2016·0 cites·46 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →